Tracked deals
161
161 tracked deals across 2010-2026.
Tracked deals
161
161 tracked deals across 2010-2026.
Buyer mix
Mixed buyer set
139 strategic · 67 pe
Top trend
Volume peaked in 2021
39 tracked deals announced in 2021.
Primary Insight
Build a buyer list for your Medical Devices deal
Find buyers actively acquiring medical devices companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| Boston Scientific Corporation | 4 | Global medical device company providing minimally invasiv... | Strategic |
| Arcline Investment Management | 3 | Growth-oriented private equity firm investing in niche, m... | PE |
| Avista Capital Partners | 3 | Private equity firm focused on growth-oriented healthcare... | PE |
| Bausch + Lomb Corporation | 3 | Global eye health company offering contact lenses, ophtha... | Strategic |
| Johnson & Johnson | 3 | Global healthcare conglomerate operating across pharmaceu... | Strategic |
| Arlington Capital Partners | 2 | Private investment firm specializing in government-regula... | PE |
| Boston Scientific | 2 | Global medical device company developing and commercializ... | Strategic |
| Laborie Medical Technologies Corp. | 2 | Global specialist medical technology company focused on u... | Strategic |
| Machine Solutions Inc. | 2 | Provider of advanced equipment and services for the medic... | Strategic (PE-backed) |
| Montagu | 2 | Mid-market private equity firm focused on growing compani... | PE |
Last 8 years
Supporting Data
InMode said its board received an unsolicited proposal from M.N. Business Strategy to acquire all outstanding ordinary shares not already owned by M.N. Business Strategy and its affiliates. The proposed merger would value the shares at $16.20 per share in cash, and InMode has formed a special committee of independent directors to evaluate the offer.
Johnson & Johnson acquired Atraverse Medical, strengthening its J&J MedTech cardiac electrophysiology portfolio. The acquisition follows the May 15, 2026 close and is referenced in connection with medtech founder John Slump’s subsequent launch of Metis MedTech.
Endologix, a privately held medical device company, announced it will acquire the Pounce Thrombectomy System from Surmodics. The FDA-cleared, fully mechanical peripheral thrombectomy platform is intended to complement Endologix’s existing vascular intervention portfolio and expand the continuum of care for patients with peripheral vascular disease.
Johnson & Johnson entered into a definitive agreement to acquire Atraverse Medical, a privately held medtech company developing the HOTWIRE Transseptal Access System for left-heart access during cardiac electrophysiology procedures. The deal is expected to close in Q2 2026, subject to customary closing conditions, with financial terms not disclosed.
Bioness Medical, Inc. announced the acquisition of the PoNS (Portable Neuromodulation Stimulator) System product line. The deal expands Bioness’s neurorehabilitation platform from functional electrical stimulation (FES) into non-invasive central neuromodulation delivered via the tongue, supporting multi-modal treatment for patients with gait and balance disorders.
Avista Healthcare Partners acquired Bentec Medical, a Woodland, California manufacturer of complex silicone-based medical device components and finished goods. The deal was announced April 8, 2026, and financial terms were not disclosed.
Merit Medical Systems acquired View Point Medical, Inc. in a transaction valued at approximately $140 million to expand its therapeutic oncology portfolio. Under the terms of the deal, Merit will pay $90 million in cash at closing plus two additional $25 million payments due on the first and second anniversaries, and View Point will become a wholly owned subsidiary of Merit.
Mechanix Wear, backed by Gryphon Investors, acquired OTEX, a developer and manufacturer of tech-enabled personal protective equipment (PPE) featuring patented safety and air-quality/cooling technologies. OTEX CEO Jake Weidert will remain with the organization as Vice President of Technology and Materials, and OTEX will operate under Mechanix Wear’s Chicago Protective Apparel division; transaction terms were not disclosed.
Symmetry Laser has completed its acquisition of ArcRev, a specialized laser cutting company with a lean manufacturing culture. The deal expands Symmetry Laser’s technical capabilities and production capacity to better support medical device customers from rapid prototyping through high-volume production.
Laborie Medical Technologies has completed the acquisition of the JADA® System and the team behind it from Organon in a transaction announced in late January 2026. The deal — part of Organon’s divestiture program (previously disclosed as up to $465 million) — brings more than 90 employees and an FDA-cleared device for rapid control of postpartum hemorrhage into Laborie’s obstetrics portfolio to expand the company’s maternal health capabilities.
Boston Scientific signed a definitive agreement to acquire Penumbra, Inc. in a cash-and-stock transaction valued at about $14.5 billion on an enterprise value basis. The deal is designed to broaden Boston Scientific’s vascular and neurovascular portfolio, particularly in mechanical thrombectomy and adjacent neurovascular markets, with expected closing in 2026 subject to regulatory approvals and Penumbra shareholder approval.
Strive, Inc. (Nasdaq: ASST) announced the completion of its acquisition of Semler Scientific, Inc. As a result of the transaction, Strive holds approximately 12,797.9 bitcoin and has appointed Avik Roy as Chief Strategy Officer to help monetize Semler's operating business and expand its early disease detection product efforts.
Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.
KVP International has acquired SafePath Laboratories and IVD Research (together SafePath-IVD), a Carlsbad, California–based diagnostics manufacturer and CDMO with FDA, ISO 13485 and USDA licenses. KVP will use SafePath-IVD as its dedicated research, development and manufacturing partner to expand veterinary point-of-care diagnostics while supporting SafePath-IVD's continued growth in human diagnostics and CDMO services.
Prescott's Med has acquired Tenacore, a Costa Mesa, California-based provider of depot-based medical device repair, parts, and technical support. The deal expands Prescott's Med's nationwide depot footprint and service capabilities for hospitals, ISOs, and in-house biomedical departments.
ARCHIMED Diagnostics (ARCHIMED’s diagnostics team) has acquired a 60% stake in Fremont-based ARK Diagnostics from Soulbrain Holdings in a transaction valuing ARK at $428 million. Soulbrain retains and reinvests in a 40% stake and the deal includes a joint-venture agreement to accelerate ARK’s product development and global expansion.
B. Braun SE has completed a full acquisition of True Digital Surgery (TDS), bringing the Goleta-based developer of robotic-assisted 3D surgical microscopy fully into its Aesculap surgical division. The deal integrates TDS's team and IP to accelerate development and global rollout of the AEOS digital exoscope platform for neurosurgery, spine and ENT procedures; financial terms were not disclosed.
MegaGen Implant, a South Korea–based dental implant manufacturer, has acquired BIOLASE, the Foothill Ranch, California–based leader in dental laser technology. The deal brings BIOLASE under MegaGen's ownership with MegaGen founder Dr. Kwang Bum Park named BIOLASE's new CEO and signals renewed investment, operational integration, and capability expansion of BIOLASE's product and service offerings.
Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management, has acquired Innova Design, Inc., a pioneer in laser bonding equipment for catheter and interventional medical device manufacturing. The acquisition expands MMT’s bonding technology suite—adding Innova’s laser bonder platforms and related capabilities—to better serve medical device OEMs globally.
ZYTOMICS, a Berlin-based cancer diagnostics company, has acquired Applied Spectral Imaging (ASI), a leader in digital imaging solutions for pathology and cytogenetics laboratories. The acquisition will integrate ASI's imaging platforms and analysis software with ZYTOMICS' reagents, automation and analytics to create an end-to-end offering for diagnostic labs and accelerate product and technology innovation.
EQT Life Sciences, together with the LSP 7 fund and EQT Health Economics strategy, co-led a $56 million Series D financing in Neuros Medical to support U.S. commercialization of the Altius direct electrical nerve stimulation system for chronic post-amputation pain. Proceeds will fund scaling of commercial operations to expand access to the FDA‑approved, non‑opioid treatment for adult amputees.
TEAM Technologies (TEAM Tech), a PE‑backed contract manufacturer, has acquired Duke Empirical, Inc., a Morgan Hill, California designer and manufacturer of advanced catheters and minimally invasive delivery systems. The transaction expands TEAM Tech’s capabilities in catheter design, precision extrusion and high‑precision assembly, strengthening its offering for interventional cardiology, neurovascular and other minimally invasive device markets.
TEAM Technologies, a portfolio company of Arlington Capital Partners, has acquired Duke Empirical, a Morgan Hill, California-based designer and manufacturer of advanced catheters and minimally invasive delivery systems. The add-on expands TEAM Tech's end-to-end medical device manufacturing capabilities — including polymer extrusion and interventional cardiovascular device production — to better serve medical device OEMs and accelerate manufacturing at scale.
Addtronics, a consolidator of niche automation technology providers and a portfolio company of Kaho Partners, has acquired DAC International, a Carpinteria, California-based manufacturer of ultra‑precision equipment for contact lens and intraocular lens production. Route 2 Capital Partners provided subordinated debt and an equity investment to support the transaction, which strengthens Addtronics' medical device/ophthalmic automation capabilities.
Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.
Eargo and hearX (maker of Lexie Hearing) have completed a merger to form LXE Hearing, combining their consumer hearing-aid brands and technology platforms. The transaction is backed by an additional $100 million investment from Patient Square Capital to support growth, product integration and expanded access in the OTC hearing-aid market.
Creative Science, a CIMA Animal Health company (portfolio company of Incline Equity Partners), has acquired Infiniti Medical LLC and its subsidiary Orthomed UK Ltd. The deal adds veterinary interventional radiology, cardiology, soft-tissue surgery and orthopedic products and training capabilities to Creative Science's animal health platform to accelerate product innovation, manufacturing scale and educational programs for veterinarians.
Plastiflex Group, the IK Partners-backed manufacturer of tubing systems, acquired two healthcare-focused businesses — Smooth-Bor Plastics (Laguna Hills, CA) and TIK d.o.o. (Kobarid, Slovenia) — as add-on acquisitions to strengthen its respiratory care and catheter manufacturing capabilities. The transactions expand Plastiflex’s product portfolio and global manufacturing footprint (bringing the Group to 12 sites) and support its buy-and-build growth plan toward ~€200m sales and ~€50m EBITDA in 2025.
Arterex has acquired Adroit USA Inc., a vertically integrated medical device contract manufacturer with facilities in Bangalore, India and a U.S. engineering lab in Milpitas, California. The deal adds over 650 employees and expanded injection molding, precision metal fabrication and assembly capabilities, strengthening Arterex’s global manufacturing footprint and offering an alternative production source to China.
Aspen Medical Products, the Irvine-based spinal orthopedics manufacturer, has acquired Advanced Orthopaedics, a manufacturer and supplier of bracing solutions and orthopedic soft goods. The acquisition expands Aspen’s product portfolio into the bracing and supports market and is intended to strengthen service to distributors, hospitals, DME suppliers and retail partners while enhancing Aspen’s global reach.
Astorg has signed a definitive agreement to acquire FUJIFILM Irvine Scientific's Medical Media Business (Irvine Scientific MBU) from FUJIFILM Irvine Scientific, adding culture and vitrification media products to its recently combined assisted reproductive technology (ART) platform created from Hamilton Thorne and Cook Medical's Reproductive Health business. The deal is an add-on designed to create a global ART MedTech leader by expanding product capabilities for fertility clinics and IVF laboratories; financial terms were not disclosed.
Stryker, a medical technologies company, announced a definitive agreement to acquire Inari Medical in an all-cash transaction valued at approximately $4.9 billion ($80 per share). Following the tender offer, the acquisition will be completed via a second-step merger at the same price, with closing anticipated by the end of Q1 2025.
Hologic, Inc. completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health, for about $350 million. Gynesonics develops the Sonata System for diagnostic intrauterine imaging and incision-less transcervical treatment of certain symptomatic uterine fibroids.
Bausch + Lomb Corporation (through an affiliate) has acquired Elios Vision, Inc., developer of the ELIOS excimer-laser MIGS system, expanding Bausch + Lomb's glaucoma surgical capabilities and complementing its cataract surgery portfolio. The ELIOS technology, currently CE marked and marketed in the EU, is undergoing pursuit of FDA approval and will be commercialized more broadly through Bausch + Lomb's global cataract surgery channels.
Lafayette Instrument, a Branford Castle Partners portfolio company, has acquired the ALZET Osmotic Pumps business from DURECT Corporation as an add-on to expand Lafayette’s life-science instrumentation offering. The acquisition strengthens Lafayette’s preclinical dosing product line and represents the fourth bolt-on for the company since Branford Castle’s 2021 investment; the deal includes senior and mezzanine debt financing.
Boston Scientific agreed to acquire Axonics, a medical technology company focused on urinary and bowel dysfunction, for $71 per share in cash, valuing the equity at approximately $3.7 billion. The boards approved the transaction, which was expected to close in the first half of 2024, and Boston Scientific later announced the acquisition closed on November 15, 2024.
MDC (Medical Device Components), a Montagu-backed precision medical components platform, has acquired Lighteum, a nitinol-based medical component manufacturer. The add-on acquisition, which closed on November 8, 2024, expands MDC's nitinol processing and rapid-prototyping capabilities and extends manufacturing footprint in San Diego, Mexicali and Australia.
Savillex, a portfolio company of Thompson Street Capital Partners (TSCP), has acquired Optimum Processing, Inc., a San Rafael-based manufacturer of custom single-use bioprocessing bags and systems. The acquisition expands Savillex's product portfolio and presence in the San Francisco Bay Area to provide end-to-end container and containment solutions for pharmaceutical, biopharmaceutical and contract manufacturing customers.
Viant (Viant Medical) has acquired Fremont, California–based Knightsbridge Plastics to add precision micro-molding and injection-molded component capabilities to its medical device design and manufacturing services. The deal expands Viant’s global centers of excellence and strengthens its end-to-end manufacturing capabilities for next‑generation medical devices and advanced drug‑delivery systems.
StarFish Medical, a North American medical device development firm, has acquired Omnica Corporation, a 40-year-old medical device design and engineering company based in Irvine, California. The acquisition expands StarFish's West Coast footprint and adds Omnica's prototyping, engineering and regulatory capabilities while retaining Omnica's existing team.
Sunrise Medical, the global assistive mobility manufacturer headquartered in Malsch, Germany, has acquired Nuprodx Inc., a Livermore, California–based maker of patented bathroom mobility and shower/tub slider systems. The deal expands Sunrise Medical’s product portfolio in bathroom mobility solutions and gives Nuprodx access to Sunrise’s larger North American and global distribution network.
Bioventus has signed a definitive agreement to sell the Advanced Rehabilitation business of its subsidiary Bioness to private equity firm Accelmed Partners for total cash consideration of $45 million (including up to $20 million in earn-outs). The divestiture reduces Bioventus' annual revenue by about $50 million and allows Bioventus to focus on its core business while Accelmed plans to invest in and expand the Bioness rehabilitation product line.
Novo Holdings led a $50 million investment in Route 92 Medical as a Series F extension, joining returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group. The financing will accelerate global commercialization of Route 92's neurovascular intervention product portfolio and support regulatory authorizations in new geographies; Novo Holdings' Noel Jee will join Route 92's board.
BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group and has renamed the business BD Advanced Patient Monitoring, based in Irvine, California. The deal expands BD's smart connected care portfolio with advanced monitoring technologies and AI-enabled clinical decision tools, and aligns the new unit within BD's Medical segment to enable integration with BD's infusion platforms and future closed-loop monitoring innovations.
Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.
Bausch + Lomb Corporation announced that an affiliate has acquired Trukera Medical (formerly TearLab) from private equity owner AccelMed Partners and other shareholders. The tuck‑in acquisition brings the ScoutPro point‑of‑care tear osmolarity diagnostic into Bausch + Lomb’s surgical portfolio to strengthen preoperative dry eye assessment and expand its U.S. surgical presence.
Boston Scientific Corporation agreed to acquire Silk Road Medical, Inc. for $27.50 per share in an all-cash transaction valuing Silk Road's equity at approximately $1.26 billion. The acquisition brings Silk Road's TransCarotid Artery Revascularization (TCAR) platform into Boston Scientific's vascular portfolio to expand treatment options for carotid artery disease and strengthen the company's vascular technology offerings.
Click Therapeutics has acquired the assets of Better Therapeutics, Inc., including the FDA-authorized digital therapeutic AspyreRx (BT-001) and development candidates BT-002, BT-003 and BT-004. Click will integrate Better’s intellectual property into its AI-enabled platform to accelerate development of obesity and cardiometabolic digital therapeutics, optimizing programs for use alongside anti-obesity and diabetes medications.
Henry Schein, Inc. completed the acquisition of a majority interest in TriMed, Inc., a Santa Clarita, California–based developer of orthopedic implants and solutions for lower and upper extremities. TriMed reported approximately $52 million in 2023 net sales; the TriMed founders will remain with the business and financial terms were not disclosed. Henry Schein said the deal will broaden its surgical product offering to IDNs and ASCs and is expected to be neutral to 2024 non-GAAP EPS and accretive thereafter.
Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring medical devices companies.
Recurring buyers mentioned on this page include Boston Scientific Corporation, Johnson & Johnson, Laborie Medical Technologies Corp., Arcline Investment Management, Endologix, Cynosure, Micro Imaging Technology, Inc., and Siemens Healthineers AG.
The page highlights acquisitions tied to cardiovascular/electrophysiology and vascular/neurovascular interventions, as well as regenerative medicine and medical aesthetics, neurorehabilitation, maternal health (postpartum hemorrhage), and supporting manufacturing capabilities.
The recent locations referenced here point to California, United States, with the listed transactions framed in connection with activity occurring there.
Yes. For example, Merit Medical Systems acquired View Point Medical for about $140 million (with cash at closing plus additional anniversary payments), while other deals note that financial terms were not disclosed.